Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 May 2016 - 16 May 2016
11 May 2016 - 13 May 2016

Turning Back the Clock on Adult Stem Cell Aging

By BiotechDaily International staff writers
Posted on 03 Oct 2011
Print article
Researchers have demonstrated they can reverse the aging process for human adult stem cells, which are responsible for helping old or damaged tissues regenerate. The study’s results could lead to medical treatments that may repair a variety of disorders that occur because of tissue damage as people age.

A research group led by the Buck Institute for Research on Aging (Novato, CA, USA) and the Georgia Institute of Technology (Atlanta, GA, USA conducted the study in cell culture, which was published in the September 1, 2011, edition of the journal Cell Cycle.

The regenerative capability of tissues and organs declines as people age. The modern day stem cell theory of aging suggests that living organisms are as old as are its tissue specific or adult stem cells. Therefore, an understanding of the molecules and processes that enable human adult stem cells to trigger self-renewal and to divide, proliferate, and then differentiate in order to rejuvenate damaged tissue might be the answer to regenerative medicine and an ultimate cure for many age-related diseases. A research group led by the Buck Institute for Research on Aging in collaboration with the Georgia Institute of Technology conducted the study that identifies what is going wrong with the biologic clock underlying the limited division of human adult stem cells as they age.

“We demonstrated that we were able to reverse the process of aging for human adult stem cells by intervening with the activity of non-protein coding RNAs originated from genomic regions once dismissed as nonfunctional ‘genomic junk,’” said Victoria Lunyak, associate professor at the Buck Institute for Research on Aging.

Related Links:
Buck Institute for Research on Aging
Georgia Institute of Technology



Print article

Channels

Genomics/Proteomics

view channel
Image: An expression of NOTCH 1 (green color) in ACC stem cells (Photo courtesy of Yale University).

Adenoid Cystic Carcinoma Stem Cells Depend on NOTCH1 and SOX10 Signaling

Cancer researchers have isolated a stem cell population from the cells making up an adenoid cystic carcinoma (ACC) tumor and showed that the signaling factors NOTCH1 and SOX10 were essential for the cancer... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

European Biotech Agreement to Promote Antigen-Drug Conjugation Technology

Two European biotech companies have joined forces to exploit and commercialize an innovative, site-specific ADC (antigen-drug conjugate) conjugation technology. ProBioGen (Berlin, Germany), a company specializing in the development and manufacture of complex glycoproteins and Eucodis Bioscience (Vienna, Austria), a... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.